Genmab | GEN - Pre Tax Profit


Genmab reported DKK295M in Pre-Tax Profit for its fiscal quarter ending in June of 2026.





Pre Tax Profit Change Date
Agios Pharmaceuticals USD -99.11M 9.94M Mar/2026
Almirall EUR 30.32M 22M Dec/2025
Amarin USD -852K 7.26M Dec/2025
Amgen USD 2.08B 570M Mar/2026
argenx SE USD 426M 22.71M Mar/2026
AstraZeneca USD 4.81B 894M Jun/2026
Bayer EUR 321M 2.67B Jun/2026
BioMarin Pharmaceutical USD 141.2M 168.36M Mar/2026
Demant DKK 1.64B 173M Dec/2025
Exelixis USD 262.68M 5.01M Jun/2026
Fresenius Medical Care EUR 383M 43M Jun/2026
Genmab DKK 295M 221M Jun/2026
GlaxoSmithKline GBP 2.68B 532M Jun/2026
GN Store Nord DKK -281M 280M Jun/2026
GRIFOLS EUR 247M 135M Jun/2026
Hikma Pharmaceutical USD 147.5M 3.5M Jun/2025
Insmed USD -11.37M 150.72M Jun/2026
Lakefront Biotherapeutics EUR 13.96M 769.2M Mar/2026
Lonza CHF 624M 197M Dec/2024
Merck EUR 869M 468M Mar/2026
Novartis USD 4.27B 430M Jun/2026
Regeneron Pharmaceuticals USD 1.53B 696.6M Jun/2026
Roche Holding CHF 11.17B 6.38B Jun/2026
Sanofi EUR 837M 1.17B Jun/2026
UCB EUR 789M 427M Jun/2025